Zexuan Su

592 total citations
31 papers, 437 citations indexed

About

Zexuan Su is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Zexuan Su has authored 31 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Zexuan Su's work include Epigenetics and DNA Methylation (8 papers), Cancer-related gene regulation (5 papers) and Renal cell carcinoma treatment (4 papers). Zexuan Su is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Cancer-related gene regulation (5 papers) and Renal cell carcinoma treatment (4 papers). Zexuan Su collaborates with scholars based in China, United Kingdom and Germany. Zexuan Su's co-authors include Caiyong Lai, Xun Wu, Liping Shi, Bin Pan, Rui Ren, Xiaohong Wang, Feng Li, Yong Wen, Xueqiong Zhou and Thomas Herrmann and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Transplantation.

In The Last Decade

Zexuan Su

30 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zexuan Su China 12 192 147 102 83 61 31 437
Hong-Lin Cheng Taiwan 14 176 0.9× 93 0.6× 75 0.7× 44 0.5× 132 2.2× 22 509
Yuantao Wang China 12 102 0.5× 114 0.8× 56 0.5× 34 0.4× 102 1.7× 40 356
Jinxian Pu China 15 248 1.3× 164 1.1× 28 0.3× 144 1.7× 52 0.9× 55 512
Chen‐Pang Hou Taiwan 13 130 0.7× 156 1.1× 134 1.3× 55 0.7× 63 1.0× 58 404
Cheng Zhao China 14 162 0.8× 65 0.4× 19 0.2× 100 1.2× 66 1.1× 30 456
Pan Song China 14 127 0.7× 112 0.8× 56 0.5× 94 1.1× 105 1.7× 49 498
Andrzej Borówka Poland 13 172 0.9× 179 1.2× 115 1.1× 72 0.9× 124 2.0× 57 475
Wenhui Zhang China 12 144 0.8× 163 1.1× 38 0.4× 87 1.0× 39 0.6× 44 503
Wenbiao Liao China 15 186 1.0× 230 1.6× 120 1.2× 83 1.0× 166 2.7× 41 571
Tian-bao Huang China 12 40 0.2× 101 0.7× 32 0.3× 60 0.7× 84 1.4× 28 352

Countries citing papers authored by Zexuan Su

Since Specialization
Citations

This map shows the geographic impact of Zexuan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zexuan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zexuan Su more than expected).

Fields of papers citing papers by Zexuan Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zexuan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zexuan Su. The network helps show where Zexuan Su may publish in the future.

Co-authorship network of co-authors of Zexuan Su

This figure shows the co-authorship network connecting the top 25 collaborators of Zexuan Su. A scholar is included among the top collaborators of Zexuan Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zexuan Su. Zexuan Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Zexuan, et al.. (2024). Chaiqin Chengqi Decoction as an adjuvant treatment for mild/moderately severe hypertriglyceridemic acute pancreatitis: A retrospective study. World Journal of Clinical Cases. 12(11). 1918–1928. 1 indexed citations
2.
Wang, Ying, et al.. (2023). The hidden inequality: the disparities in the quality of daily use masks associated with family economic status. Frontiers in Public Health. 11. 1163428–1163428. 2 indexed citations
3.
Li, Qiang, Zifan He, Jiming Liu, et al.. (2019). Paris polyphylla 26 triggers G2/M phase arrest and induces apoptosis in HepG2 cells via inhibition of the Akt signaling pathway. Journal of International Medical Research. 47(4). 1685–1695. 6 indexed citations
4.
Su, Zexuan, et al.. (2018). SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis. Journal of Nippon Medical School. 85(2). 78–86. 12 indexed citations
5.
Shi, Liping, et al.. (2017). Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma. International Urology and Nephrology. 49(7). 1165–1176. 22 indexed citations
6.
Wang, Xiaohong, et al.. (2016). Eupatilin induces human renal cancer cell apoptosis via ROS-mediated MAPK and PI3K/AKT signaling pathways. Oncology Letters. 12(4). 2894–2899. 56 indexed citations
7.
Lai, Caiyong, et al.. (2016). Engrailed-2 might play an anti-oncogenic role in clear-cell renal cell carcinoma. Journal of Molecular Histology. 47(3). 229–237. 11 indexed citations
8.
9.
Guo, Hongbo, et al.. (2016). Expression and clinical significance of Apollon in renal carcinoma. Oncology Letters. 12(6). 5129–5135. 2 indexed citations
10.
Li, Yunfei, et al.. (2015). Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo. Oncology Reports. 33(5). 2319–2330. 10 indexed citations
11.
Lai, Caiyong, et al.. (2015). Aberrant Methylation of RASSF1A gene Contribute to the Risk of Renal Cell Carcinoma: a Meta-Analysis. Asian Pacific Journal of Cancer Prevention. 16(11). 4665–4669. 8 indexed citations
12.
13.
14.
Wang, Zhifeng, et al.. (2014). Modified single-port minilaparoscopic extraperitoneal repair for pediatric hydrocele: a single-center experience with 279 surgeries. World Journal of Urology. 32(6). 1613–1618. 14 indexed citations
15.
Wang, Xiaohong, et al.. (2014). Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients. Tumor Biology. 35(10). 9839–9845. 9 indexed citations
16.
Liu, Yun, et al.. (2014). Serum Fractalkine and Interferon-Gamma Inducible Protein-10 Concentrations Are Early Detection Markers for Acute Renal Allograft Rejection. Transplantation Proceedings. 46(5). 1420–1425. 14 indexed citations
17.
Lai, Caiyong, Bin Pan, Yun Luo, et al.. (2014). Engrailed-2 is down-regulated but also ectopically expressed in clear cell renal cell carcinoma. Molecular Biology Reports. 41(6). 3651–3657. 9 indexed citations
18.
Wang, Zhifeng, et al.. (2014). Invasive Management of Proximal Ureteral Calculi During Pregnancy. Urology. 83(4). 745–749. 22 indexed citations
19.
Lai, Caiyong, et al.. (2014). A recommended technique of renal vein anastomosis in rat kidney transplantation for trainee. Chinese Medical Journal. 127(10). 1919–1923. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong-Lin Cheng Breakdown of academic impact, for papers by Yuantao Wang Breakdown of academic impact, for papers by Jinxian Pu Breakdown of academic impact, for papers by Chen‐Pang Hou Breakdown of academic impact, for papers by Cheng Zhao Breakdown of academic impact, for papers by Pan Song Breakdown of academic impact, for papers by Andrzej Borówka Breakdown of academic impact, for papers by Wenhui Zhang Breakdown of academic impact, for papers by Wenbiao Liao Breakdown of academic impact, for papers by Tian-bao Huang
Rankless by CCL
2026